Imamura S, Mori K, Yasojima H, Mizutani M, et al. Genomically determined subtypes and clinicopathological features as predictors of the efficacy of preoperative chemotherapy combined with HER2-targeted therapy for early-stage HER2-positive breast cancer. BMC Cancer 2025;25:1707.
PMID: 41188730